hyaluronoglucosaminidase has been researched along with Sclerosis, Systemic in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (78.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (3.57) | 29.6817 |
2010's | 4 (14.29) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Brehm, JE; Chopra, D; Morrison, B | 1 |
Asano, Y; Cai, X; Ito, T; Kawashima, Y; Matsuura, M; Ohta, S; Okochi, H; Sato, S; Taniguchi, M | 1 |
Hunt, KM; Jacobson, ES; Melvin, OG | 1 |
Kumar, KS; Kumar, MH; Kumar, MS; Kumar, SH | 1 |
Do, L; Engström-Laurent, A; Hellman, U; Kämpe, O; Kerje, S; Larsson, G; Lindqvist, U | 1 |
CLAESSON, U; LINDQUIST, B | 1 |
JOHANSSON, S; MOLLER, F | 1 |
GOLDSBOROUGH, D; SHARP, J | 1 |
KUBIN, J; WENDLBERGER, J | 1 |
POPKIN, RJ | 2 |
Connolly, MK; Neudecker, BA; Stern, R | 1 |
Konopík, J; Krs, V | 1 |
Didenko, IG | 1 |
Arnerić, S; Janković, D; Mladenović, P; Stanković, K | 1 |
Nitzschner, H | 1 |
Braun, W; Wozniak, KD | 2 |
Ishikawa, H; Kitabatake, M; Uchiyama, Y | 1 |
Balda, BR | 1 |
Wüthrich, B | 1 |
Fischer, H; Tronnier, H | 1 |
Bellmann, H; Petter, O | 2 |
Herrmann, WP; Mahrle, G; Steigleder, GK | 1 |
Sych, LI; Trofimova, LIa | 1 |
Poy, C | 1 |
Grimmer, H | 1 |
2 trial(s) available for hyaluronoglucosaminidase and Sclerosis, Systemic
Article | Year |
---|---|
[Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Ultrasonic Therapy; Ultrasonics | 1978 |
[Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
Topics: Clinical Trials as Topic; Humans; Hyaluronoglucosaminidase; Keloid; Scleroderma, Localized; Scleroderma, Systemic | 1972 |
26 other study(ies) available for hyaluronoglucosaminidase and Sclerosis, Systemic
Article | Year |
---|---|
Hyaluronidase as a Successful Treatment Modality for Scleroderma-Induced Microstomia.
Topics: Humans; Hyaluronoglucosaminidase; Microstomia; Scleroderma, Localized; Scleroderma, Systemic | 2022 |
Facile fabrication of PEG-coated PLGA microspheres via SPG membrane emulsification for the treatment of scleroderma by ECM degrading enzymes.
Topics: Animals; Cattle; Collagenases; Colloids; Disease Models, Animal; Emulsions; Extracellular Matrix; Glass; Hyaluronoglucosaminidase; Iron; Membranes, Artificial; Mice; Microspheres; Particle Size; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Scleroderma, Systemic; Skin; Swine | 2019 |
Hyaluronidase Treatment of Scleroderma-Induced Microstomia.
Topics: Female; Humans; Hyaluronoglucosaminidase; Microstomia; Middle Aged; Scleroderma, Systemic; Treatment Outcome | 2019 |
A neoteric multidrug combination: novel approach to limited cutaneous systemic scleroderma involving the face.
Topics: Dexamethasone; Drug Therapy, Combination; Face; Female; Glucocorticoids; Humans; Hyaluronoglucosaminidase; Mouth; Scleroderma, Systemic; Skin; Tooth Extraction | 2016 |
Is low molecular weight hyaluronan an early indicator of disease in avian systemic sclerosis?
Topics: Animal Structures; Animals; CD3 Complex; Chickens; Collagen; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunoglobulins; Immunohistochemistry; Inflammation; Molecular Weight; Scleroderma, Systemic; Staining and Labeling; Water | 2016 |
Use of hyaluronidase in scleroderma.
Topics: Basidiomycota; Humans; Hyaluronoglucosaminidase; Scleroderma, Localized; Scleroderma, Systemic | 1953 |
Hyaluronidase in scleroderma.
Topics: Basidiomycota; Humans; Hyaluronoglucosaminidase; Scleroderma, Localized; Scleroderma, Systemic | 1957 |
The dermal barrier in systemic sclerosis and other rheumatic diseases.
Topics: Collagen Diseases; Humans; Hyaluronoglucosaminidase; Rheumatic Diseases; Scleroderma, Systemic; Skin Physiological Phenomena | 1958 |
[Hyaluronidase-iontophoresis in sclerodermia circumscripta].
Topics: Humans; Hyaluronoglucosaminidase; Ion Exchange; Iontophoresis; Scleroderma, Systemic | 1954 |
The use of hyaluronidase by iontophoresis in the treatment of generalized scleroderma.
Topics: Humans; Hyaluronoglucosaminidase; Iontophoresis; Scleroderma, Systemic | 1951 |
The use of hyaluronidase in the treatment of chronic skin ulcers in diffuse generalized scleroderma.
Topics: Chronic Disease; Humans; Hyaluronoglucosaminidase; Scleroderma, Systemic; Skin Ulcer | 1952 |
Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
Topics: Adult; Aged; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Middle Aged; Scleroderma, Systemic; Time Factors | 2004 |
[Treatment of scleroderma with depolymerizing agents].
Topics: Bromhexine; Female; Humans; Hyaluronoglucosaminidase; Male; Scleroderma, Localized; Scleroderma, Systemic | 1982 |
[Our experience in the treatment of progressive scleroderma with hyaluronidase].
Topics: Adult; Female; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Scleroderma, Systemic | 1975 |
[Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Topics: Carnitine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Hyaluronoglucosaminidase; Scleroderma, Localized; Scleroderma, Systemic | 1975 |
[Treatment with hyaluronidase in dermatology].
Topics: Humans; Hyaluronoglucosaminidase; Keloid; Male; Penile Induration; Scleroderma, Localized; Scleroderma, Systemic; Skin Diseases | 1975 |
Significant increase of urinary low-sulfated heparan-sulfate-related protein in patients with severe systemic scleroderma.
Topics: Adult; Aged; Aged, 80 and over; Antigen-Antibody Reactions; Antigens; Chemical Fractionation; Female; Glycosaminoglycans; Humans; Hyaluronoglucosaminidase; Immunodiffusion; Middle Aged; Radioimmunoassay; Scleroderma, Systemic; Sodium Chloride | 1987 |
[Treatment of generalized (progressive) scleroderma].
Topics: Ammotherapy; Female; Glucocorticoids; Heparinoids; Humans; Hyaluronoglucosaminidase; Male; Ointments; Penicillamine; Physical Therapy Modalities; Progesterone; Scleroderma, Systemic | 1972 |
[Treatment of scleroderma].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Antimalarials; Azathioprine; Dextrans; Edetic Acid; Female; Humans; Hyaluronoglucosaminidase; Male; Scleroderma, Localized; Scleroderma, Systemic; Sympatholytics | 1973 |
[On the differentiation of changes in the skin under various edematous conditions].
Topics: Connective Tissue; Edema; Exudates and Transudates; Glycosaminoglycans; Humans; Hyaluronoglucosaminidase; Myxedema; Scleroderma, Systemic; Water-Electrolyte Balance | 1965 |
[Treatment of systemic scleroderma with high dosage of intravenous hyaluronidase].
Topics: Adult; Female; Glycosaminoglycans; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Middle Aged; Radiography; Scleroderma, Systemic | 1971 |
[Hyaluronidase therapy of progressive scleroderma].
Topics: Adult; Ambulatory Care; Female; Gymnastics; Hospitalization; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Joints; Male; Massage; Middle Aged; Scleroderma, Systemic | 1972 |
[Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Topics: Adult; Female; Histocytochemistry; Humans; Hyaluronoglucosaminidase; Male; Middle Aged; Penicillins; Scleroderma, Localized; Scleroderma, Systemic | 1971 |
[Theoretical aspects of the new possibilities of use of hyaluronidase].
Topics: Adult; Basal Metabolism; Collagen; Female; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Middle Aged; Progesterone; Scleroderma, Systemic | 1971 |
[Prophylaxis and enzymatic therapy in high doses of collagenoses with cicatricial evolution].
Topics: Adult; Female; Humans; Hyaluronoglucosaminidase; Scleroderma, Systemic | 1965 |
[1. Progressive scleroderma. 2. Pustular palmo-plantar psoriasis].
Topics: Aged; Chondroitin; Female; Foot Dermatoses; Hand Dermatoses; Humans; Hyaluronoglucosaminidase; Scleroderma, Systemic; Sulfates | 1966 |